The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Breast Cancer–Related Lymphedema: Comparing Direct Costs of a Prospective Surveillance Model and a Traditional Model of Care
Open accessAbstract
Secondary prevention involves monitoring and screening to prevent negative sequelae from chronic diseases such as cancer. Breast cancer treatment sequelae, such as lymphedema, may occur early or late and often negatively affect function. Secondary prevention through prospective physical therapy surveillance aids in early identification and treatment of breast cancer–related lymphedema (BCRL). Early intervention may reduce the need for intensive rehabilitation and may be cost saving. This perspective article compares a prospective surveillance model with a traditional model of impairment-based care and examines direct treatment costs associated with each program. Intervention and supply costs were estimated based on the Medicare 2009 physician fee schedule for 2 groups: (1) a prospective surveillance model group (PSM group) and (2) a traditional model group (TM group). The PSM group comprised all women with breast cancer who were receiving interval prospective surveillance, assuming that one third would develop early-stage BCRL. The prospective surveillance model includes the cost of screening all women plus the cost of intervention for early-stage BCRL. The TM group comprised women referred for BCRL treatment using a traditional model of referral based on late-stage lymphedema. The traditional model cost includes the direct cost of treating patients with advanced-stage lymphedema. The cost to manage early-stage BCRL per patient per year using a prospective surveillance model is $636.19. The cost to manage late-stage BCRL per patient per year using a traditional model is $3,124.92. The prospective surveillance model is emerging as the standard of care in breast cancer treatment and is a potential cost-saving mechanism for BCRL treatment. Further analysis of indirect costs and utility is necessary to assess cost-effectiveness. A shift in the paradigm of physical therapy toward a prospective surveillance model is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Cited by
Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments
Gillespie, T. C., Sayegh, H. E., Brunelle, C. L., Daniell, K. M., & Taghian, A. G. (2018) · Gland Surgery · doi:10.21037/gs.2017.11.04 · Cited by 361
Lymphedema following breast cancer treatment and impact on quality of life: A review
Taghian, N. R., Miller, C. L., Jammallo, L. S., O’Toole, J., & Skolny, M. N. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.06.004 · Cited by 333
Hidding, J. T., Beurskens, C. H. G., van der Wees, P. J., van Laarhoven, H. W. M., & Nijhuis-van der Sanden, M. W. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096748 · Cited by 337
Manual lymphatic drainage for lymphedema following breast cancer treatment
Ezzo, J., Manheimer, E., McNeely, M. L., Howell, D. M., Weiss, R., Johansson, K. I., Bao, T., Bily, L., Tuppo, C. M., Williams, A. F., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003475.pub2 · Cited by 323
Lymphedema after Breast Cancer Treatment
Rockson, S. G. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1803290 · Cited by 277
Recent progress in the treatment and prevention of cancer‐related lymphedema
Shaitelman, S. F., Cromwell, K. D., Rasmussen, J. C., Stout, N. L., Armer, J. M., Lasinski, B. B., & Cormier, J. N. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21253 · Cited by 255
Self-citationDeveloping High-Quality Cancer Rehabilitation Programs: A Timely Need
Alfano, C. M., Cheville, A. L., & Mustian, K. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156164 · Cited by 107
Metadata
- Authors
- Stout, N. L., Pfalzer, L. A., Springer, B., Levy, E., McGarvey, C. L., Danoff, J. V., Gerber, L. H., & Soballe, P. W.
- Venue
- Physical Therapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-01
- Volume
- 92
- Issue
- 1
- Pages
- 152-163
- ISSN
- 0031-9023 (ISSN-L)
- 1538-6724
- OpenAlex
- W2101839815
- Cited by
- 211
- References
- 1
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.